Srdjan Stankovic, MD, MSPH
- 4Articles
- 35.2KReads
- 2015–2020Active
- 19Collaborators
- 175Citations
About
Srdjan Stankovic, MD, MSPH, has published research on pharmacological treatments in psychiatry, focusing on schizophrenia, schizoaffective disorders, and major depressive disorder. His work includes clinical trials investigating adjunctive pimavanserin for major depressive disorder and aripiprazole lauroxil for acute schizophrenia, examining both efficacy and safety profiles. Stankovic's articles appeared in Psychiatrist.com between 2015 and 2020.
Publications
Adjunctive Pimavanserin and Sleep/Wakefulness in MDD
December 1, 2020
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
